## Background: Ifosfamide and cisplatin are active agents that are currently used in the treatment of osteosarcoma. nephrotoxicity has been reported following their use in combination and alone. this study evaluates renal function in children and adolescents (median age 16 years) at least 3 months
Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma
โ Scribed by Dr Jeffrey C. Allen; Gerald Rosen
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 434 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Two patients, aged 24 and 19 years, who had undifferentiated lymphoma, developed the acute onset of focal neurologic deficits 10 days after treatment with moderate-dose methotrexate (2.76 g/m2 by 42-hour intravenous infusion) and 12.5 mg of intrathecal methotrexate. Prior chemotherapy also included
Gonadal functions were evaluated in 92 male patients after treatment for advanced Hodgkin's disease. The patients received six to ten cycles of cyclophosphamide, vincristine, procarbazine, and prednisolone (COPP) chemotherapy. All patients were in remission and were followed for 1 to 17 years (media
## Background: In the past 20 years, it has been demonstrated that the combination of surgery and chemotherapy improves the prognosis for patients with osteosarcoma of the extremity without detectable metastases at presentation. by contrast, the efficacy of chemotherapy coupled with aggressive surg